Last reviewed · How we verify

NCT06777225

Breathing Exercise Application in Patients With Gynecological Cancer.

ENROLLING BY INVITATION NA Last updated 15 January 2025
What this trial tests

NA trial testing breathing exercises in Gynecological Cancer in 104 participants. Enrolling by invitation.

Timeline
1 December 2024
Primary endpoint
31 March 2025
31 July 2025

Quick facts

Lead sponsorÇankırı Karatekin University
PhaseNA
StatusENROLLING BY INVITATION
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingsingle
Primary purposesupportive care
Enrollment104
Start date1 December 2024
Primary completion31 March 2025
Estimated completion31 July 2025
Sites1 location across Turkey (Türkiye)

Drugs / interventions tested

Conditions studied

Sponsor

Çankırı Karatekin University

Who can join

Adults 18 to 65, female only, with Gynecological Cancer. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The aim of this study is to determine the effects of breathing exercises on nausea, vomiting and anxiety levels in patients with gynecological cancer.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of breathing exercises

Trials testing the same drug.

Other recruiting trials for Gynecological Cancer

Currently open trials in the same condition.

Other Çankırı Karatekin University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06777225.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing